Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions

被引:1
作者
Kozlina, Filip [1 ]
Mestrovic, Ivan [1 ]
Novak, Viktor [1 ]
Marjanovic, Nikola [2 ]
Cetina-Cizmek, Biserka [2 ]
机构
[1] Univ Zagreb, Fac Pharm & Biochem, A Kovacica 1, Zagreb 10000, Croatia
[2] PLIVA Croatia Ltd, TEVA Grp Member, Prilaz Baruna Filipovica 25, Zagreb 10000, Croatia
来源
ADMET AND DMPK | 2022年
关键词
dissolution; prolonged release injection; parenterals; derivative spectroscopy; DISSOLUTION/RELEASE METHODS; EXTENDED-RELEASE; ABSORPTION; SUSPENSIONS;
D O I
10.5599/admet.1465
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
For many parenteral drugs, there is still no standardized method for in vitro release (IVR) testing available. This article presents the development of a new IVR method for oil solutions using a dialysis membrane and USP II apparatus coupled to a fiber optic UV-Vis spectrometer. Experiments were performed using dexamethasone formulations containing castor oil as a solvent with the addition of cosolvents, 20 % (v/v) of isopropanol or Capryol (R) 90. Based on solubility testing results, castor oil was chosen as the best solvent amongst other vegetable oils, while a significant increase in solubility was obtained by adding either of the two cosolvents. Partitioning experiments were performed to ensure these formulations could achieve prolonged drug release. IVR testing was performed with model formulations and critical test parameters were varied in order to examine the method's sensitivity. The developed method was sensitive to temperature and stirring rate, while coupling the USP II apparatus with a fiber optic UV-Vis spectrometer enabled complete automation. Moreover, due to the interference of excipients on fiber optic detection of dexamethasone during the release testing, derivative spectroscopy was successfully introduced for the elimination of the interference. The developed IVR method described herein could be useful in preformulation investigations and the early development of novel formulations. (c) 2022 by the authors.This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:15
相关论文
共 24 条
[1]  
Abrahamson B., 2004, PHARM PREFORMULATION, P239
[2]  
Burgess Diane J, 2004, Eur J Pharm Sci, V21, P679, DOI 10.1016/j.ejps.2004.03.001
[3]   In Vitro Release Test Methods for Drug Formulations for Parenteral Applications [J].
Gray, Vivian ;
Cady, Susan ;
Curran, David ;
DeMuth, James ;
Eradiri, Okponanabofa ;
Hussain, Munir ;
Kraemer, Johannes ;
Shabushnig, John ;
Stippler, Erika .
DISSOLUTION TECHNOLOGIES, 2018, 25 (04) :8-13
[4]  
Jug M, 2017, ADMET DMPK, V5, P173, DOI 10.5599/admet.5.3.425
[5]   An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems [J].
Jug, Mario ;
Hafner, Anita ;
Lovric, Jasmina ;
Kregar, Maja Lusina ;
Pepic, Ivan ;
Vanic, Zeljka ;
Cetina-Cizmek, Biserka ;
Filipovic-Grcic, Jelena .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 147 :350-366
[6]   Fundamental understanding of drug absorption from a parenteral oil depot [J].
Kalicharan, Raween W. ;
Schot, Peter ;
Vromans, Herman .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 83 :19-27
[7]   Assessment of rate of drug release from oil vehicle using a rotating dialysis cell [J].
Larsen, DH ;
Fredholt, K ;
Larsen, C .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 (03) :223-229
[8]  
Larsen SW, 2012, ADV DEL SCI TECHNOL, P113, DOI 10.1007/978-1-4614-0554-2_7
[9]   In vitro and in vivo release of dinalbuphine sebacate extended release formulation: Effect of the oil ratio on drug release [J].
Li, Chan-Jung ;
Ku, Mei-Yun ;
Lu, Chia-Yin ;
Tien, Yu-En ;
Chern, Wendy H. ;
Huang, Jin-ding .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 531 (01) :306-312
[10]  
Lu Xujin., 2003, DISSOLUT TECHNOL, V10, P6, DOI DOI 10.1002/jps.22214